Skip to main content
. 2025 Aug 21;15:30704. doi: 10.1038/s41598-025-13330-7

Table 1.

Demographics, Disease Characteristics and Clinical Outcomes of Patients with Spinal Cord Hemangioblastoma by Race.

Total
(N = 716)
No. (%)
White (N = 599)
No. (%)
Black (N = 88)
No. (%)
Asian (N = 29)
No. (%)
p-value
Age, mean (SD), years 49.4 (15.9) 50.2 (16.0) 46.6 (14.8) 42.6 (14.1) 0.009
Sex 0.184
Female 344 (48.0) 279 (46.6) 50 (56.8) 15 (51.7)
Male 372 (52.0) 320 (53.4) 38 (43.2) 14 (48.3)
Facility Type 0.202
Academic/Research Program 540 (75.4) 445 (74.3) 69 (78.4) 26 (89.7)
Community Cancer Program 7 (1.0) 6 (1.0) 0 (0.0) 1 (3.4)
Comprehensive Community Cancer Program 104 (14.5) 92 (15.4) 10 (11.4) 2 (6.9)
Integrated Network Cancer Program 65 (9.1) 56 (9.3) 9 (10.2) 0 (0.0)
Insurance Status 0.008
Private Insurance 457 (63.8) 390 (65.1) 51 (58.0) 16 (55.2)
Medicare 149 (20.8) 129 (21.5) 15 (17.0) 5 (17.2)
Medicaid 70 (9.8) 46 (7.7) 18 (20.5) 6 (20.7)
Other Government 9 (1.3) 9 (1.5) 0 (0.0) 0 (0.0)
Not Insured 31 (4.3) 25 (4.2) 4 (4.5) 2 (6.9)
Median Income quartile  < 0.001
Highest 323 (45.1) 276 (46.1) 32 (36.4) 15 (51.7)
High—Middle 167 (23.3) 147 (24.5) 12 (13.6) 8 (27.6)
Middle—Low 133 (18.6) 116 (19.4) 16 (18.2) 1 (3.4)
Lowest 93 (13.0) 60 (10.0) 28 (31.8) 5 (17.2)
Residential Location 0.796
Metro 634 (88.5) 529 (88.3) 78 (88.6) 27 (93.1)
Rural 6 (0.8) 6 (1.0) 0 (0.0) 0 (0.0)
Urban 76 (10.6) 64 (10.7) 10 (11.4) 2 (6.9)
Distance from home to facilities, Mean (SD), miles 53.2 ± 111.5 57.7 ± 119.9 28.8 ± 37.7 35.9 ± 59.1 0.053
Charlson-Deyo Comorbidity Classification (CDCC) scores 0.043
0 575 (80.3) 490 (81.8) 60 (68.2) 25 (86.2)
1 90 (12.6) 69 (11.5) 18 (20.5) 3 (10.3)
 ≥ 2 51 (7.1) 40 (6.7) 10 (11.4) 1 (3.4)
Tumor Size, Mean (SD), mm 62.2 (72.5) 62.6 (69.7) 65.5 (96.2) 42.6 (33.5) 0.313
Treatment 0.432
Surgery alone 623 (87.0) 515 (86.0) 81 (92.0) 27 (93.1)
Radiation alone 17 (2.4) 16 (2.7) 1 (1.1) 0 (0.0)
Surgery with Radiation 76 (10.6) 68 (11.4) 6 (6.8) 2 (6.9)
Surgical Techniques 0.551
Open 386 (95.5%) 311 (95.1%) 57 (98.3%) 18 (94.7%)
MIS 18 (4.5%) 16 (4.9%) 1 (1.7%) 1 (5.3%)
Na 312 272 30 10
Extent of Resection 0.206
GTR 688 (98.4) 576 (98.8) 84 (96.6) 28 (96.6)
STR 11 (1.6) 7 (1.2) 3 (3.4) 1 (3.4)
Duration from diagnosis to surgery, Mean (SD), days 24.4 ± 55.0 23.8 ± 51.4 19.5 ± 40.1 52.0 ± 123.6 0.018
Primary Site 0.68
Spinal Cord 705 (98.5%) 590 (98.5%) 86 (97.7%) 29 (100%)
Cauda Equina 11 (1.5%) 9 (1.5%) 2 (2.3%) 0 (0%)
Radiation Therapy 0.172
Yes 93 (13.1) 84 (14.2) 7 (8.0) 2 (6.9)
No 616 (86.9) 509 (85.8) 80 (92.0) 27 (93.1)
Radiation Modality 0.382
Photon 60 (64.5) 54 (64.3) 4 (57.1) 2 (100.0)
Brachytherapy 33 (35.5) 30 (35.7) 3 (42.9) 0 (0.0)
Total Dose, Mean (SD), cGy 3968.0 ± 1740.3 3855.7 ± 1755.3 4890.0 ± 1571.4 4500.0 (NA) 0.374
Clinical Outcomes

Follow-up Time,

Mean (SD), months

69.0 (42.5) 68.7 (43.1) 72.7 (39.9) 64.5 (36.8) 0.598

Length of stay,

Mean (SD), days

5.6 (6.5) 5.4 (6.3) 6.5 (8.1) 6.0 (4.3) 0.333
30-day Readmission rate 46 (6.4) 34 (5.7) 9 (10.2) 3 (10.3) 0.181
Mortality rates
30-day 3 (0.5) 3 (0.6) 0 (0.0) 0 (0.0) 0.744
90-day 9 (1.4) 9 (1.7) 0 (0.0) 0 (0.0) 0.412
5-year 63 (8.8) 57 (9.5) 5 (5.7) 1 (3.4) 0.289
10-year 88 (12.3) 82 (13.7) 5 (5.7) 1 (3.4) 0.034
Long-term 94 (13.1) 88 (14.7) 5 (5.7) 1 (3.4) 0.019

GTR, gross total resection; STR, subtotal resection.